CH465139A - Verfahren zur Herstellung von stabilisierten Phospholipoid-Präparaten mit hämostatischer Wirkung - Google Patents

Verfahren zur Herstellung von stabilisierten Phospholipoid-Präparaten mit hämostatischer Wirkung

Info

Publication number
CH465139A
CH465139A CH1552063A CH1552063A CH465139A CH 465139 A CH465139 A CH 465139A CH 1552063 A CH1552063 A CH 1552063A CH 1552063 A CH1552063 A CH 1552063A CH 465139 A CH465139 A CH 465139A
Authority
CH
Switzerland
Prior art keywords
phospholipoid
preparations
stabilized
production
hemostatic effect
Prior art date
Application number
CH1552063A
Other languages
German (de)
English (en)
Inventor
Anraku Takao
Nagashima Renpei
Kobayashi Toshio
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CH465139A publication Critical patent/CH465139A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/42—Polyamides containing atoms other than carbon, hydrogen, oxygen, and nitrogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
    • D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
    • D01F8/12—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyamide as constituent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Textile Engineering (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH1552063A 1962-12-20 1963-12-18 Verfahren zur Herstellung von stabilisierten Phospholipoid-Präparaten mit hämostatischer Wirkung CH465139A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5611862 1962-12-20

Publications (1)

Publication Number Publication Date
CH465139A true CH465139A (de) 1968-11-15

Family

ID=13018141

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1552063A CH465139A (de) 1962-12-20 1963-12-18 Verfahren zur Herstellung von stabilisierten Phospholipoid-Präparaten mit hämostatischer Wirkung

Country Status (7)

Country Link
US (1) US3279993A (enEXAMPLES)
BE (1) BE641559A (enEXAMPLES)
CH (1) CH465139A (enEXAMPLES)
DE (1) DE1203909B (enEXAMPLES)
FR (1) FR3104M (enEXAMPLES)
GB (1) GB1018647A (enEXAMPLES)
NL (1) NL302091A (enEXAMPLES)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185529A (en) * 1980-06-30 1985-04-16 Jose A. Arias-Alvarez Antithrombotic treatment
EP0055702B1 (en) * 1980-06-30 1987-04-08 T And R Chemicals, Inc. Antithrombotic treatment
EP1462109B1 (en) * 2003-03-28 2008-02-13 D.M.G. Italia Srl Hemostatic, emollient and lubricating preparations containing pork fat extract (lard)
US20060019868A1 (en) 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US8440225B2 (en) 2003-08-07 2013-05-14 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2047144A (en) * 1934-03-26 1936-07-07 Lilly Co Eli Stabilized epinephrine-type compound, and process of stabilizing it
US2719812A (en) * 1953-08-07 1955-10-04 Merck & Co Inc Stabilized aqueous solutions of streptomycin
US2970944A (en) * 1958-04-04 1961-02-07 Merck & Co Inc Parenteral solutions of steroid phosphates stabilized with creatinines

Also Published As

Publication number Publication date
DE1203909B (de) 1965-10-28
NL302091A (enEXAMPLES)
FR3104M (fr) 1965-02-01
BE641559A (enEXAMPLES) 1964-04-16
GB1018647A (en) 1966-01-26
US3279993A (en) 1966-10-18

Similar Documents

Publication Publication Date Title
CH457490A (de) Verfahren zur Herstellung von N-Acylcysteinen
CH457674A (de) Verfahren zur Herstellung von Pigmentpräparaten
CH465139A (de) Verfahren zur Herstellung von stabilisierten Phospholipoid-Präparaten mit hämostatischer Wirkung
CH430677A (de) Verfahren zur Herstellung von p-Aminoarylaldehyden
AT258685B (de) Verfahren zur Herstellung von genußfähigen Zubereitungen
AT242863B (de) Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen
CH435303A (de) Verfahren zur Herstellung von 2-Chlor-s-triazinen
AT250582B (de) Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden
CH469721A (de) Verfahren zur Herstellung von 3-Acrylamino-pyrazinamido-guanidinen
CH450405A (de) Verfahren zur Herstellung von 19-Hydroxy- 4-3-keto-steroiden
CH431511A (de) Verfahren zur Herstellung von 1a-Alkylthio-3-keto-steroiden
CH427812A (de) Verfahren zur Herstellung von Oxathiazolinonen
CH429729A (de) Verfahren zur Herstellung von Aminoisoxazolen
AT241433B (de) Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden
CH440265A (de) Verfahren zur Herstellung von 19-Norsteroiden
CH443283A (de) Verfahren zur Herstellung von 3-Methylen-steroidenn
CH441349A (de) Verfahren zur Herstellung von s-Tetrazinen
CH431518A (de) Verfahren zur Herstellung von 16B-Niederalkylthio-17B-hydroxy-östren-3-onen
AT238877B (de) Verfahren zur Herstellung von elektrolytarmen Farbstoffpräparaten
AT248431B (de) Verfahren zur Herstellung von Cyanpyridinen
AT257064B (de) Verfahren zur Herstellung von 16α-Hydroxysteroiden
AT242149B (de) Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin
CH435302A (de) Verfahren zur Herstellung von 3-Alkoxy-4-nitro-6-alkylpyridazin-1-oxyden
CH441298A (de) Verfahren zur Herstellung von 8B-Methyl-11B-oxysteroiden
CH478110A (de) Verfahren zur Herstellung von 5a- 1-Androstenolen